Issued Patents All Time
Showing 1–25 of 61 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12214047 | FAP-activated proteasome inhibitors for treating solid tumors | Hung-sen Lai, Sarah E. Poplawski | 2025-02-04 |
| 12121505 | Fap-activated therapeutic agents, and uses related thereto | Hung-sen Lai, David G. Sanford, Sarah E. Poplawski, Wengen Wu | 2024-10-22 |
| 12053450 | FAP-activated therapeutic agents, and uses related thereto | Hung-sen Lai, David G. Sanford, Sarah E. Poplawski, Wengen Wu | 2024-08-06 |
| 12023316 | FAP-activated therapeutic agents, and uses related thereto | Hung-sen Lai, David G. Sanford, Sarah E. Poplawski, Wengen Wu | 2024-07-02 |
| 11957657 | Combination therapies using immuno-dash inhibitors and PGE2 antagonists | Hung-sen Lai, Wengen Wu | 2024-04-16 |
| 11925655 | FAP-activated therapeutic agents, and uses related thereto | Hung-sen Lai, David G. Sanford, Sarah E. Poplawski, Wengen Wu | 2024-03-12 |
| 11707539 | FAP-targeted radiopharmaceuticals and imaging agents, and uses related thereto | Hung-sen Lai, Wengen Wu | 2023-07-25 |
| 11583516 | Dash inhibitors, and uses related thereto | Hung-sen Lai, Wengen Wu | 2023-02-21 |
| 11559537 | Combination therapies using caspase-1 dependent anticancer agents and PGE2 antagonists | Hung-sen Lai, Wengen Wu | 2023-01-24 |
| 11266669 | FAP-activated therapeutic agents, and uses related thereto | Hung-sen Lai, David G. Sanford, Sarah E. Poplawski, Wengen Wu | 2022-03-08 |
| 11096924 | Combination therapies using immuno-dash inhibitors and PGE2 antagonists | Hung-sen Lai, Wengen Wu | 2021-08-24 |
| 11065339 | FAP-activated proteasome inhibitors for treating solid tumors | Hung-sen Lai, Sarah E. Poplawski | 2021-07-20 |
| 11033525 | Fap-activated therapeutic agents, and uses related thereto | Hung-sen Lai, David G. Sanford, Sarah E. Poplawski, Wengen Wu | 2021-06-15 |
| 10709722 | FAP-activated therapeutic agents, and uses related thereto | Hung-sen Lai, David G. Sanford, Sarah E. Poplawski, Wengen Wu | 2020-07-14 |
| 10517955 | FAP-activated proteasome inhibitors for treating solid tumors | Hung-sen Lai, Sarah E. Poplawski | 2019-12-31 |
| 10245248 | FAP-activated therapeutic agents, and uses related thereto | Hung-sen Lai, David G. Sanford, Sarah E. Poplawski, Wengen Wu | 2019-04-02 |
| 10117887 | FAP-activated therapeutic agents, and uses related thereto | Hung-sen Lai, David G. Sanford, Sarah E. Poplawski, Wengen Wu | 2018-11-06 |
| 9956297 | FAP-activated proteasome inhibitors for treating solid tumors | Hung-sen Lai, Sarah E. Poplawski | 2018-05-01 |
| 9839646 | Small molecule enhancer for dendritic cell cancer vaccines | — | 2017-12-12 |
| 9757400 | Peptidomimetic inhibitors of post-proline cleaving enzymes | — | 2017-09-12 |
| 9737556 | FAP-activated therapeutic agents, and uses related thereto | Hung-sen Lai, David G. Sanford, Sarah E. Poplawski, Wengen Wu | 2017-08-22 |
| 9629921 | Smart pro-drugs of serine protease inhibitors | — | 2017-04-25 |
| 9597410 | FAP-activated proteasome inhibitors for treating solid tumors | Hung-sen Lai, Sarah E. Poplawski | 2017-03-21 |
| 9511060 | Non-flushing niacin analogues, and methods of use thereof | Hung-sen Lai | 2016-12-06 |
| 9284337 | Small molecule enhancer for dendritic cell cancer vaccines | — | 2016-03-15 |